Patent directory · USPTO A61K / A61P
Patents matching “immunotherapy”
175 pharma patents match "immunotherapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 175 pharmaceutical patents matching "immunotherapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 6565827
Radioimmunotherapy of lymphoma using anti-CD20 antibodies
expired -
US 6287537
Radioimmunotherapy of lymphoma using anti-CD20 antibodies
expired -
US 6277368
Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine
expired -
US 6224866
Immunotherapy of B cell involvement in progression of solid, nonlymphoid tumors
expired -
US 6207147
Cancer immunotherapy using tumor cells combined with mixed lymphocytes
expired -
US 6090365
Radioimmunotherapy of lymphoma using anti-CD20 antibodies
expired -
US 6015542
Radioimmunotherapy of lymphoma using anti-CD20 antibodies
expired